Cancer Research and Advances
Chronic Stress and Obesity May Promote Pancreatic Cancer Growth via CREB Activation, Study Suggests
Key Takeaways Stress and obesity may contribute to pancreatic cancer: Both factors activate biological pathways that may accelerate tumor growth. Women may be more vulnerable: Hormonal differences could heighten stress-related …Metformin and Syrosingopine: Diabetes and Blood Pressure Drugs Show Promise Against Cancer in Early Study
Key Takeaways: A drug pairing of metformin (diabetes medication) and syrosingopine (blood pressure drug) shows potential for starving cancer cells. The combo blocks two critical energy pathways cancer cells …
Prostate Cancer MRI Scans May Underestimate Tumor Size: UCLA Study Warns of Treatment Risks
Key Takeaways: Prostate cancer is the second leading cause of cancer death in U.S. men, but early detection boosts survival rates to nearly 100%. Age, family history, and race …
Study Finds Coffee and Tea Reduce Risk of Certain Head and Neck Cancers, but Excessive Tea Consumption May Increase Risk of Laryngeal Cancer
Researchers have highlighted the positive effects of coffee and tea in reducing the risk of developing head and neck cancers. Consumed daily by hundreds of millions worldwide, coffee and …
Evaluating Multi-Cancer Early Detection Tests: The GRAIL-Galleri Test’s Sensitivity, Economic Implications, and Challenges in Screening Effectiveness
Early detection of cancer is crucial for improving patient outcomes. As cancer remains one of the leading causes of death worldwide, there is an increasing demand for effective screening …
Clinical Trials Assess NP-137’s Impact on Pancreatic Cancer Progression
Pancreatic cancer is one of the most fatal cancers affecting people worldwide. In 2015, over 411,00 people died of pancreatic cancer, globally. In 2020, an estimated 95,000 people were …
Possible Solution for Cancer Pain Through Electrical Stimulation of the Pituitary Gland
Globally, the prevalence of cancer has risen, with a projected increase in the number of annual cases from 14 million to 32 million in 2032. If detected early, cancer …
Exploring Selinexor’s Efficacy in P53-Mutated Endometrial Cancer: Insights from Recent Clinical Trials
Selinexor (XPOVIO®) is an anti-cancer drug used in the treatment of various malignant conditions including a condition called refractory multiple myeloma. This is multiple myeloma that is not responsive …